Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Elusys Bags $143m US Government Contract
Elusys Therapeutics (Elusys) has signed a contract totaling $143m with the US Government to complete the final development, commercial manufacturing and licensure of Anthim, a late stage anthrax
Elusys Therapeutics (Elusys) has signed a contract totaling $143m with the US Government to complete the final development, commercial manufacturing and licensure of Anthim, a late stage anthrax
Millennium has reported that the FDA has approved Takeda Oncology’s (Takeda) supplemental new drug application (sNDA) for Velcade, which expands the label to include long-term (median follow-up 36.7
Pearl Therapeutics (Pearl) has reported positive results from phase 2a dose-ranging study of PT005, a formoterol fumarate hydrofluoroalkane metered dose inhaler (HFA-MDI) formulation, in patients with chronic obstructive
Optigenex has entered into a long term exclusive license agreement with Promethean for distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11. AC-11 is a
Advaxis has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980, titled ‘Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens,’ has
Irvine Scientific has received CE mark for a full range of its media designed for Assisted Reproductive Technologies (ART), complete P-1 medium with DSS, blastocyst freeze media, blastocyst
The Medicines Company has filed lawsuits against Teva Parenteral Medicines (Teva), Pliva Hrvatska and related entities in the US District Court for the District of Delaware alleging patent
Microfluidic Systems (MFSI) has been awarded a series of patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens
Winner Medical Group (Winner Medical) has opened its first three PurCotton pilot chain stores in Shenzhen, Guangdong province, China. At the same time, its subsidiary, Winner Industries (Shenzhen)
The FDA has accepted to review the New Drug Application (NDA) seeking marketing approval for the investigational drug, Retigabine developed by Valeant Pharmaceuticals International (Valeant). Retigabine is a